- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Keratotic Nodular Size in Hong Kong
Total 1381 results
-
University of WashingtonNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical Carcinoma | Cervical Undifferentiated Carcinoma | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer | Stage... and other conditionsUnited States, Hong Kong, Canada
-
Rain Oncology IncTerminatedNSCLC Stage IIIB | NSCLC, Recurrent | NRG1 Fusion | EGFR Exon 20 Insertion Mutation | NSCLC, Stage IIIC | NSCLC, Stage IV | HER2-activating Mutation | ERBB FusionUnited States, Canada, Hong Kong
-
AstraZenecaIonis Pharmaceuticals, Inc.CompletedAdvanced Adult Hepatocellular Carcinoma | Hepatocellular Carcinoma MetastaticKorea, Republic of, Taiwan, Hong Kong, Japan
-
Progen PharmaceuticalsTerminatedCancer | Hepatocellular Carcinoma | Primary Liver Cancer | Liver Cancer | HepatomaHong Kong, Singapore, United States, Australia, Canada, Italy, Malaysia, Spain, Taiwan, Thailand
-
National Cancer Centre, SingaporePfizerActive, not recruitingNSCLC Stage IV | NSCLC Stage IIIB | Recurrent NSCLC | NSCLC Stage IIIC | EGFR Positive Non-Small Cell Lung CancerKorea, Republic of, Hong Kong, Thailand, Singapore, Malaysia
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedLung CancerAustralia, Singapore, Hong Kong, Korea, Republic of
-
Hoffmann-La RocheCompletedCarcinoma, HepatocellularUnited States, Hong Kong, Taiwan, Singapore
-
National Cancer Institute (NCI)CompletedRecurrent Squamous Cell Carcinoma of the Nasopharynx | Stage IV Squamous Cell Carcinoma of the NasopharynxUnited States, Singapore, China
-
PfizerTerminatedAdvanced Breast Cancer (Parts 1 and 2) | Advanced Pancreatic Cancer (Part 1) | Advanced Colorectal Cancer (Part 1) | Advanced Cholangiocarcinoma (Part 1) | Advanced Glioblastoma Multiforme (Part 1)United States, Spain, Hong Kong, Belgium, Australia, France
-
Novartis PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Hong Kong, Taiwan, Korea, Republic of
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Korea, Republic of, Taiwan, Thailand
-
PfizerTerminatedBreast CancerUnited States, Belgium, Hungary, China, Hong Kong, Poland, Singapore
-
Uppsala UniversityBaylor College of Medicine; Sahlgrenska University Hospital, Sweden; University... and other collaboratorsRecruitingBreast Cancer | Breast Neoplasms | Sentinel Lymph Node | DCISUnited States, Sweden, Hong Kong
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
BayerCompletedCarcinoma, HepatocellularHong Kong, Taiwan, Korea, Republic of, Singapore
-
Taiho Pharmaceutical Co., Ltd.TerminatedHead and Neck CancerUnited States, Hong Kong, Singapore, Taiwan
-
AllerganCompleted
-
Hoffmann-La RocheCompletedCarcinoma, Hepatocellular | Liver Metastases | Biliary Tract Cancer | Secondary Liver CancerKorea, Republic of, Denmark, Spain, Taiwan, United States, Hong Kong
-
AstraZenecaTerminated
-
GlaxoSmithKlineCompletedNeoplasms, OvarianTaiwan, Hong Kong, China, Korea, Republic of
-
Zai Lab (Shanghai) Co., Ltd.TerminatedGastric Cancer | Triple Negative Breast Cancer | Endometrial Carcinoma | Biliary Tract CarcinomaChina
-
Puma Biotechnology, Inc.CompletedBreast CancerSpain, United Kingdom, France, United States, Denmark, Hong Kong
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerTaiwan, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationTerminatedCancer | Hepatocellular Carcinoma | Liver CancerKorea, Republic of, Taiwan, Hong Kong, China
-
Novartis PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Taiwan, Germany, Italy, Hong Kong, Canada, Japan, Spain
-
Sidney Kimmel Comprehensive Cancer Center at Johns...WithdrawnHead and Neck Cancer | DysphagiaUnited States, China, Australia, Canada
-
Ethicon, Inc.RecruitingLung NeoplasmsUnited States, Hong Kong, Canada
-
Eli Lilly and CompanyCompletedHepatocellular CarcinomaChina, Taiwan, Thailand, Korea, Republic of, Hong Kong
-
ASLAN PharmaceuticalsCompletedGastric CancerEstonia, Hong Kong, Korea, Republic of, Lithuania, Malaysia, Singapore, Taiwan, Thailand
-
Novartis PharmaceuticalsActive, not recruitingMelanoma | Carcinoma, Non-Small-Cell Lung | Nasopharyngeal Carcinoma | Triple Negative Breast Cancer | Microsatellite Stable Colorectal CancerUnited States, Taiwan, Spain, Germany, Japan, Hong Kong
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerHong Kong, Taiwan, Philippines, China, Thailand, Indonesia, Australia, Korea, Republic of
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
Boston Scientific CorporationCompletedPancreatic CarcinomaAustralia, France, Japan, Belgium, Hong Kong, Italy, China, India, United States
-
Novartis PharmaceuticalsActive, not recruitingALK-positive NSCLCBelgium, Spain, Italy, Australia, United States, Hong Kong, Canada, Singapore
-
Boehringer IngelheimCompletedBreast NeoplasmsHong Kong, Taiwan, United Kingdom, Russian Federation, India, Poland
-
TularikUnknownHepatocellular CarcinomaUnited States, China
-
Novartis PharmaceuticalsCompletedPre-menopausal Breast Cancer | PI3K Pathway InhibitionTaiwan, Hong Kong, Thailand, Korea, Republic of
-
Yiviva Inc.RecruitingAdvanced Hepatocellular CarcinomaUnited States, Taiwan, China, Hong Kong
-
Arbutus Biopharma CorporationCompletedHepatocellular Carcinoma | Hepatoma | Liver Cancer, Adult | Liver Cell Carcinoma, AdultUnited States, Taiwan, Singapore, China, Canada, Korea, Republic of
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerChina, Hong Kong, Russian Federation, Singapore
-
PfizerCompletedStomach NeoplasmsKorea, Republic of, Portugal, Taiwan, Italy, Hong Kong, China, Japan
-
GC Cell CorporationCompletedHepatocellular CarcinomaKorea, Republic of
-
AbbVieAvailableNon-Small Cell Lung Cancer (NSCLC)Australia, Hong Kong, Israel, United States, Germany
-
Kyoto Breast Cancer Research NetworkPfizerCompletedHormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer FemaleTaiwan, Japan, Korea, Republic of, Australia, Hong Kong
-
BayerTerminatedCarcinoma, Non-Small-Cell LungChina, Taiwan, Singapore, Thailand, Korea, Republic of, India
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, Spain, Belgium, Hong Kong, France
-
Omega TherapeuticsRecruitingHepatocellular Carcinoma | Solid Tumor | Liver Cancer | Hepatocellular Carcinoma Non-resectable | Hepatocellular Cancer | Hepatocellular Carcinoma Recurrent | Liver, Cancer of, Non-ResectableUnited States, Hong Kong, Korea, Republic of, Singapore, Taiwan
-
National Cancer Institute (NCI)CompletedRecurrent Nasopharynx Carcinoma | Stage III Nasopharyngeal Carcinoma AJCC v7 | Stage IV Nasopharyngeal Carcinoma AJCC v7 | Stage IVA Nasopharyngeal Carcinoma AJCC v7 | Stage IVB Nasopharyngeal Carcinoma AJCC v7 | Stage IVC Nasopharyngeal Carcinoma AJCC v7 | Nasopharyngeal Nonkeratinizing CarcinomaUnited States, Singapore, China
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerChina, Hong Kong, Taiwan, Philippines, Thailand, Korea, Republic of, Indonesia